Summary
13 / 100 · Bulios Score
Valuation 0Growth -Profitability 15Quality 9Debt 0Stability 50
What speaks for it
- It holds more cash than debt: $607.5K against $559.3K.
- It bought back its own shares for $26.9M in the last fiscal year, 44% of its market value.
What to watch
- The company made a loss over the last 12 months.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Revenue (USD)
20212022202320242025
Diluted EPS (USD)
20212022202320242025
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $67.6M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $607.5K
Debt $559.3K
Free cash flow over 12 months -$962.4K
Over the last 12 months it spent more cash than it brought in. It holds more cash than debt. The debt score is low because of the debt-to-equity ratio.
Financial health in detailDoes it pay a dividend?
No20212022202320242025
It pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.